Ex-Teva Scientist Testifies In Copaxone Patent Battle
A former Teva Pharmaceutical Industries Ltd. scientist testified Monday in New York that the company uncovered safety concerns as it was developing multiple sclerosis drug Copaxone, necessitating patents that generics makers...To view the full article, register now.
Already a subscriber? Click here to view full article